Domenica Rubino
7PUBLICATIONS
23CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (7)
Sort by Publication Date:
|Dec 02, 2025
CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1.Subodh Verma, Morten Böttcher, Paul Brown
|Jan 10, 2025
Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT-1 to -4 trials.Domenica M Rubino, Sue D Pedersen, Lisa Connery
|May 03, 2024
Effect of semaglutide 2.4 mg on physical functioning and weight- and health-related quality of life in adults with overweight or obesity: Patient-reported outcomes from the STEP 1-4 trials.Domenica Rubino, Jakob B Bjorner, Naveen Rathor
|Jul 10, 2023
A model-based approach to predict individual weight loss with semaglutide in people with overweight or obesity.Anders Strathe, Deborah B Horn, Malte Selch Larsen
|Jan 24, 2023
Exploring the wider benefits of semaglutide treatment in obesity: insight from the STEP program.Patrick M O'Neil, Domenica M Rubino
Pageof 2
Frequent Collaborators
4 joint publications
Sean Wharton
2 joint publications
Dror Dicker
1 joint publications
Melanie Davies
1 joint publications
Ildiko Lingvay
1 joint publications
Ofri Mosenzon
1 joint publications
Sue D Pedersen
1 joint publications
Patrick M O'Neil
1 joint publications
Anders Strathe
1 joint publications
Deborah B Horn
1 joint publications
Malte Selch Larsen